James J. Marino, Director at Celldex Therapeutics, Inc. (CLDX), bought 40,000 shares at $0.48 ($19K) on 2018-08-24, disclosed to the SEC on 2018-08-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ONTX | BUY | 2020-11-27 | $10K | — | Filing → |
| CLDX | BUY | 2020-06-10 | $25K | — | Filing → |
| ONTX | BUY | 2019-11-26 | $30K | — | Filing → |